Health Care Equipment & Services

Garipalli Vivek’s latest Clover Health purchase shows insider confidence in its Medicare‑advantage model, confirming long‑term commitment amid market volatility.

Butterfly Network CFO sells 60k shares to cover taxes—an ordinary liquidity move, not a sign of weakness, as the stock stays under 52‑week highs.

Cosmos Health CEO’s insider buy signals confidence amid debt‑to‑equity conversion and new Libytec partnership—watch how this shapes the company’s future.

Penumbra insider selling under Rule 10b5‑1 shows disciplined portfolio management, not distress; the company’s strong neurovascular growth and robust fundamentals keep investors confident in a bullish market.

Broadwood’s surge in STAAR Surgical shares signals confidence as the company pivots back to high‑margin implantable lenses and glaucoma devices, leveraging FDA approvals and a robust safety record to drive future value.

Rothberg’s rule‑based sale of 1.14 M Butterfly Network shares amid strong price momentum raises questions: can the AI‑driven portable imaging firm stay profitable and competitive as regulators tighten scrutiny and rivals expand their own ecosystems?…

Outset Medical’s insider sell‑to‑cover activity shows no loss of confidence; with breakthrough device status and Phase IIb gains, investors should watch upcoming FDA/EMA decisions and the CEO’s J.P. Morgan conference for future valuation clues.

Insider Armbrister buys 79,365 Clover Health shares, boosting his stake to 6.8%. The move signals board confidence in the company’s Medicare Advantage strategy and long‑term value.

Insightful review of Kewaunee Scientific’s CEO insider sales shows strategic equity moves, not a loss of confidence, and how such patterns signal future company shifts.